Rhonda Rhyne

Rhonda Rhyne has over 25 years of experience in the health care industry, working with both public and private companies and as a health care provider. Rhonda served as president of CardioDynamics, a publicly-traded, innovative cardiovascular medical device company, from 1997 until 2009, when the company was sold to SonoSite. Prior to joining CardioDynamics, Rhonda held positions of CEO, VP of sales and marketing, and board director at Culture Technology, Inc., a privately-held biotechnology company specializing in culturing autologous skin for burn patients.

Throughout her career, Rhonda has been recognized as an industry leader with honors that include: Entrepreneur of the Year–Medical Products, Ernst & Young, 2003; Fast 50 Award for 50 Fastest Growing Technology/Life Science Companies in Southern California, Deloitte, 1999–2007; and Women Who Mean Business Award, San Diego Business Journal, 2000. Rhonda earned an MBA from the UCLA Anderson School of Business Administration and a bachelor’s degree in Pharmacy from Washington State University.